The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome
2011

Using Ultra-Dense Array CGH to Find Cancer Gene Changes

publication Evidence: high

Author Information

Author(s): Ewa Przybytkowski, Cristiano Ferrario, Mark Basik

Primary Institution: Lady Davis Institute, Sir Mortimer B. Davis Jewish General Hospital, McGill University

Hypothesis

Can ultra-dense array CGH effectively detect micro-copy number alterations and gene fusions in cancer genomes?

Conclusion

The study demonstrates that the 1 M array CGH platform can detect micro-CNAs and gene fusions with high sensitivity, but requires high-quality genomic DNA.

Supporting Evidence

  • The 1 M array platform showed a 4-fold increase in resolution compared to the 244 K array.
  • Fifteen micro-CNAs were detected only by the 1 M array, indicating its higher sensitivity.
  • The study identified intra-genic breakpoints that may signal gene fusion events.

Takeaway

This study shows that a special DNA test can find tiny changes in cancer genes that might help doctors understand and treat cancer better.

Methodology

Array CGH was performed on whole genome amplified and non-amplified genomic DNA from MCF-7 breast cancer cells using 244 K and 1 M Agilent arrays.

Potential Biases

The use of whole genome amplification may introduce artifacts that confound the analysis.

Limitations

The study did not compare DNA from fresh or frozen cells versus that extracted from paraffin-embedded samples.

Participant Demographics

MCF-7 breast cancer cell line was used.

Statistical Information

P-Value

0.0055

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1755-8794-4-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication